122 related articles for article (PubMed ID: 9488202)
1. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin.
Folts JD
Int J Cardiol; 1997 Dec; 62 Suppl 2():S111-7. PubMed ID: 9488202
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
Roux SP; Sakariassen KS; Turitto VT; Baumgartner HR
Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
[TBL] [Abstract][Full Text] [Related]
3. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Harmsze AM; Robijns K; van Werkum JW; Breet NJ; Hackeng CM; Ten Berg JM; Ruven HJ; Klungel OH; de Boer A; Deneer VH
Thromb Haemost; 2010 May; 103(5):920-5. PubMed ID: 20352154
[TBL] [Abstract][Full Text] [Related]
4. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
Folts JD; Rowe GG
Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
[TBL] [Abstract][Full Text] [Related]
5. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
[TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152).
Sordahl LA; Rex KA; Benedict CR
J Cardiovasc Pharmacol; 1991 Oct; 18(4):504-10. PubMed ID: 1724526
[TBL] [Abstract][Full Text] [Related]
7. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Beaughard M; Brasset M; John G; Massingham R
J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effect of aspirin in patients with coronary artery disease.
Grove EL
Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
Hennan JK; Hong TT; Willens DE; Driscoll EM; Giboulot TA; Lucchesi BR
Br J Pharmacol; 2002 Jul; 136(6):927-37. PubMed ID: 12110617
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of anti-platelet agents as adjuncts to tissue plasminogen activator in a dog model of occlusive coronary thrombosis.
McAuliffe SJ; Moors JA; Jones HB
Br J Pharmacol; 1994 May; 112(1):272-6. PubMed ID: 8032650
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
[TBL] [Abstract][Full Text] [Related]
14. Human platelet Ca2+ mobilization, glycoprotein IIb/IIIa activation, and experimental coronary thrombosis in vivo in dogs are all inhibited by the inotropic agent amrinone.
Sill JC; Bertha B; Berger I; Uhl C; Nugent M; Folts J
Circulation; 1997 Sep; 96(5):1647-53. PubMed ID: 9315560
[TBL] [Abstract][Full Text] [Related]
15. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
[TBL] [Abstract][Full Text] [Related]
16. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
[TBL] [Abstract][Full Text] [Related]
17. Thrombostatin inhibits induced canine coronary thrombosis.
Hasan AA; Rebello SS; Smith E; Srikanth S; Werns S; Driscoll E; Faul J; Brenner D; Normolle D; Lucchesi BR; Schmaier AH
Thromb Haemost; 1999 Sep; 82(3):1182-7. PubMed ID: 10494785
[TBL] [Abstract][Full Text] [Related]
18. Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis.
Folts JD; Gering SA; Laibly SW; Bertha BG; Bonebrake FC; Keller JW
Adv Exp Med Biol; 1990; 273():339-58. PubMed ID: 2288288
[TBL] [Abstract][Full Text] [Related]
19. Mouse antithrombotic assay: the effects of Ca++ channel blockers are platelet-independent.
Molinari A; Guarneri L; Pacei E; de Marchi F; Cerletti C; de Gaetano G
J Pharmacol Exp Ther; 1987 Feb; 240(2):623-7. PubMed ID: 3806414
[TBL] [Abstract][Full Text] [Related]
20. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis.
Makkar RR; Eigler NL; Kaul S; Frimerman A; Nakamura M; Shah PK; Forrester JS; Herbert JM; Litvack F
Eur Heart J; 1998 Oct; 19(10):1538-46. PubMed ID: 9820993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
